Aug. 13 at 2:29 AM
$CMPX Compass Therapeutics Prices
$120M Public Offering at
$3.00/Share
Compass Therapeutics priced an underwritten public offering of 33.29M shares at
$3.00 each and 6.71M pre-funded warrants at
$2.9999. Gross proceeds are expected to total ~
$120M before expenses. The oncology-focused biotech is developing proprietary antibody-based therapeutics for multiple human diseases.